annual cash & cash equivalents:
$3.27B+$449.80M(+15.96%)Summary
- As of today (June 22, 2025), LLY annual cash & cash equivalents is $3.27 billion, with the most recent change of +$449.80 million (+15.96%) on December 31, 2024.
- During the last 3 years, LLY annual cash & cash equivalents has fallen by -$550.10 million (-14.41%).
- LLY annual cash & cash equivalents is now -55.35% below its all-time high of $7.32 billion, reached on December 31, 2018.
Performance
LLY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$3.09B-$175.10M(-5.36%)Summary
- As of today (June 22, 2025), LLY quarterly cash & cash equivalents is $3.09 billion, with the most recent change of -$175.10 million (-5.36%) on March 31, 2025.
- Over the past year, LLY quarterly cash & cash equivalents has increased by +$633.10 million (+25.73%).
- LLY quarterly cash & cash equivalents is now -65.48% below its all-time high of $8.96 billion, reached on September 30, 2018.
Performance
LLY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LLY Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.0% | +25.7% |
| 3 y3 years | -14.4% | +25.8% |
| 5 y5 years | +39.8% | +82.1% |
LLY Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | +58.1% | -12.8% | +49.6% |
| 5 y | 5-year | -14.4% | +58.1% | -19.0% | +82.1% |
| alltime | all time | -55.4% | +911.9% | -65.5% | +1242.6% |
LLY Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.09B(-5.4%) |
| Dec 2024 | $3.27B(+16.0%) | $3.27B(-3.0%) |
| Sep 2024 | - | $3.37B(+4.5%) |
| Jun 2024 | - | $3.22B(+31.0%) |
| Mar 2024 | - | $2.46B(-12.7%) |
| Dec 2023 | $2.82B(+36.4%) | $2.82B(+18.4%) |
| Sep 2023 | - | $2.38B(-11.6%) |
| Jun 2023 | - | $2.69B(-24.0%) |
| Mar 2023 | - | $3.55B(+71.5%) |
| Dec 2022 | $2.07B(-45.9%) | $2.07B(-21.0%) |
| Sep 2022 | - | $2.62B(-0.2%) |
| Jun 2022 | - | $2.62B(+6.7%) |
| Mar 2022 | - | $2.46B(-35.6%) |
| Dec 2021 | $3.82B(+4.4%) | $3.82B(+0.8%) |
| Sep 2021 | - | $3.79B(+17.6%) |
| Jun 2021 | - | $3.22B(+7.2%) |
| Mar 2021 | - | $3.00B(-17.9%) |
| Dec 2020 | $3.66B(+56.5%) | $3.66B(+1.7%) |
| Sep 2020 | - | $3.60B(+52.0%) |
| Jun 2020 | - | $2.37B(+39.2%) |
| Mar 2020 | - | $1.70B(-27.3%) |
| Dec 2019 | $2.34B(-68.1%) | $2.34B(+49.5%) |
| Sep 2019 | - | $1.56B(-31.7%) |
| Jun 2019 | - | $2.29B(+12.5%) |
| Mar 2019 | - | $2.04B(-72.2%) |
| Dec 2018 | $7.32B(+12.0%) | $7.32B(-18.3%) |
| Sep 2018 | - | $8.96B(+31.4%) |
| Jun 2018 | - | $6.82B(+121.0%) |
| Mar 2018 | - | $3.08B(-52.8%) |
| Dec 2017 | $6.54B(+42.6%) | $6.54B(+75.5%) |
| Sep 2017 | - | $3.72B(+21.3%) |
| Jun 2017 | - | $3.07B(+17.3%) |
| Mar 2017 | - | $2.62B(-42.9%) |
| Dec 2016 | $4.58B(+25.0%) | $4.58B(+31.3%) |
| Sep 2016 | - | $3.49B(+7.8%) |
| Jun 2016 | - | $3.24B(+40.3%) |
| Mar 2016 | - | $2.31B(-37.1%) |
| Dec 2015 | $3.67B(-5.3%) | $3.67B(+13.2%) |
| Sep 2015 | - | $3.24B(-2.3%) |
| Jun 2015 | - | $3.32B(+8.2%) |
| Mar 2015 | - | $3.06B(-20.8%) |
| Dec 2014 | $3.87B(+1.1%) | $3.87B(+22.3%) |
| Sep 2014 | - | $3.17B(-15.9%) |
| Jun 2014 | - | $3.77B(-3.1%) |
| Mar 2014 | - | $3.89B(+1.5%) |
| Dec 2013 | $3.83B(-4.7%) | $3.83B(-12.3%) |
| Sep 2013 | - | $4.37B(+15.4%) |
| Jun 2013 | - | $3.79B(-3.8%) |
| Mar 2013 | - | $3.94B(-2.0%) |
| Dec 2012 | $4.02B(-32.1%) | $4.02B(-24.4%) |
| Sep 2012 | - | $5.32B(+22.4%) |
| Jun 2012 | - | $4.35B(+5.4%) |
| Mar 2012 | - | $4.12B(-30.4%) |
| Dec 2011 | $5.92B(-1.2%) | $5.92B(-10.2%) |
| Sep 2011 | - | $6.60B(+7.9%) |
| Jun 2011 | - | $6.11B(-6.0%) |
| Mar 2011 | - | $6.51B(+8.6%) |
| Dec 2010 | $5.99B(+34.3%) | $5.99B(+16.1%) |
| Jun 2010 | - | $5.16B(+9.3%) |
| Mar 2010 | - | $4.73B(+5.9%) |
| Dec 2009 | $4.46B(-18.8%) | $4.46B(+16.0%) |
| Sep 2009 | - | $3.85B(+15.8%) |
| Jun 2009 | - | $3.32B(+0.3%) |
| Mar 2009 | - | $3.31B(-39.7%) |
| Dec 2008 | $5.50B(+70.7%) | $5.50B(+26.3%) |
| Sep 2008 | - | $4.35B(+51.8%) |
| Jun 2008 | - | $2.87B(-8.8%) |
| Mar 2008 | - | $3.15B(-2.3%) |
| Dec 2007 | $3.22B(+3.6%) | $3.22B(+29.1%) |
| Sep 2007 | - | $2.50B(+12.4%) |
| Jun 2007 | - | $2.22B(-10.9%) |
| Mar 2007 | - | $2.49B(-19.9%) |
| Dec 2006 | $3.11B | $3.11B(+43.3%) |
| Sep 2006 | - | $2.17B(-18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $2.67B(+8.6%) |
| Mar 2006 | - | $2.46B(-18.2%) |
| Dec 2005 | $3.01B(-44.0%) | $3.01B(-39.5%) |
| Sep 2005 | - | $4.97B(+7.1%) |
| Jun 2005 | - | $4.64B(-17.2%) |
| Mar 2005 | - | $5.61B(+4.5%) |
| Dec 2004 | $5.37B(+94.7%) | $5.37B(+108.2%) |
| Sep 2004 | - | $2.58B(+7.5%) |
| Jun 2004 | - | $2.40B(-0.6%) |
| Mar 2004 | - | $2.41B(-12.5%) |
| Dec 2003 | $2.76B(+41.6%) | $2.76B(-5.5%) |
| Sep 2003 | - | $2.92B(+43.1%) |
| Jun 2003 | - | $2.04B(-7.6%) |
| Mar 2003 | - | $2.20B(+13.3%) |
| Dec 2002 | $1.95B(-28.0%) | $1.95B(-30.2%) |
| Sep 2002 | - | $2.79B(-8.7%) |
| Jun 2002 | - | $3.05B(+5.9%) |
| Mar 2002 | - | $2.88B(+6.6%) |
| Dec 2001 | $2.70B(-34.3%) | $2.70B(+2.1%) |
| Sep 2001 | - | $2.65B(-11.0%) |
| Jun 2001 | - | $2.97B(-8.0%) |
| Mar 2001 | - | $3.23B(-21.5%) |
| Dec 2000 | $4.11B(+11.2%) | $4.11B(+32.0%) |
| Sep 2000 | - | $3.12B(-7.5%) |
| Jun 2000 | - | $3.37B(-11.3%) |
| Mar 2000 | - | $3.80B(+2.6%) |
| Dec 1999 | $3.70B(+147.4%) | $3.70B(+12.4%) |
| Sep 1999 | - | $3.29B(+62.0%) |
| Jun 1999 | - | $2.03B(-15.5%) |
| Mar 1999 | - | $2.40B(+60.8%) |
| Dec 1998 | $1.50B(-23.2%) | $1.50B(-3.1%) |
| Sep 1998 | - | $1.54B(+17.4%) |
| Jun 1998 | - | $1.32B(+4.0%) |
| Mar 1998 | - | $1.26B(-35.1%) |
| Dec 1997 | $1.95B(+139.3%) | $1.95B(+29.5%) |
| Sep 1997 | - | $1.50B(-18.8%) |
| Jun 1997 | - | $1.85B(+77.8%) |
| Mar 1997 | - | $1.04B(+28.1%) |
| Dec 1996 | $813.70M(-18.6%) | $813.70M(+10.2%) |
| Sep 1996 | - | $738.10M(-34.4%) |
| Jun 1996 | - | $1.13B(+25.2%) |
| Mar 1996 | - | $898.40M(-10.1%) |
| Dec 1995 | $999.50M(+86.2%) | $999.50M(+2.4%) |
| Sep 1995 | - | $976.20M(-1.4%) |
| Jun 1995 | - | $989.70M(+1.1%) |
| Mar 1995 | - | $978.80M(+82.3%) |
| Dec 1994 | $536.90M(-0.5%) | $536.90M(-46.3%) |
| Sep 1994 | - | $999.60M(+41.4%) |
| Jun 1994 | - | $706.80M(+16.8%) |
| Mar 1994 | - | $604.90M(+12.1%) |
| Dec 1993 | $539.60M(+24.8%) | $539.60M(-15.2%) |
| Sep 1993 | - | $636.10M(+42.1%) |
| Jun 1993 | - | $447.70M(-24.7%) |
| Mar 1993 | - | $594.60M(+37.5%) |
| Dec 1992 | $432.40M(-9.8%) | $432.40M(+21.7%) |
| Sep 1992 | - | $355.20M(-16.5%) |
| Jun 1992 | - | $425.40M(+21.1%) |
| Mar 1992 | - | $351.30M(-26.7%) |
| Dec 1991 | $479.20M(+36.8%) | $479.20M(+63.3%) |
| Sep 1991 | - | $293.50M(+27.4%) |
| Jun 1991 | - | $230.40M(-23.9%) |
| Mar 1991 | - | $302.80M(-13.5%) |
| Dec 1990 | $350.20M(+8.4%) | $350.20M(-29.1%) |
| Sep 1990 | - | $494.00M(+7.6%) |
| Jun 1990 | - | $459.10M(+9.5%) |
| Mar 1990 | - | $419.30M(+29.8%) |
| Dec 1989 | $323.00M(-57.6%) | $323.00M(-45.0%) |
| Sep 1989 | - | $587.40M(+2.6%) |
| Jun 1989 | - | $572.40M(-24.8%) |
| Dec 1988 | $761.50M(-26.1%) | $761.50M(-26.1%) |
| Dec 1987 | $1.03B(+112.1%) | $1.03B(+112.1%) |
| Dec 1986 | $486.00M(+19.7%) | $486.00M(+19.7%) |
| Dec 1985 | $406.10M(-8.8%) | $406.10M(-8.8%) |
| Dec 1984 | $445.30M | $445.30M |
FAQ
- What is Eli Lilly and Company annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Eli Lilly and Company?
- What is Eli Lilly and Company annual cash & cash equivalents year-on-year change?
- What is Eli Lilly and Company quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly cash & cash equivalents year-on-year change?
What is Eli Lilly and Company annual cash & cash equivalents?
The current annual cash & cash equivalents of LLY is $3.27B
What is the all time high annual cash & cash equivalents for Eli Lilly and Company?
Eli Lilly and Company all-time high annual cash & cash equivalents is $7.32B
What is Eli Lilly and Company annual cash & cash equivalents year-on-year change?
Over the past year, LLY annual cash & cash equivalents has changed by +$449.80M (+15.96%)
What is Eli Lilly and Company quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LLY is $3.09B
What is the all time high quarterly cash & cash equivalents for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly cash & cash equivalents is $8.96B
What is Eli Lilly and Company quarterly cash & cash equivalents year-on-year change?
Over the past year, LLY quarterly cash & cash equivalents has changed by +$633.10M (+25.73%)